Investors
A leading antibody innovation powerhouse
We are a fast-growing, international biotech company committed to improving the lives of people with our differentiated antibody medicines.
We have committed to a new vision for our future that by 2030, our knock-your-socks-off “KYSO” antibody medicines are fundamentally transforming the lives of people with cancer and other serious diseases.